The drug trial is being funded by a £300,000 ($386,882) grant from Alzheimer’s Research UK and will explore the effectiveness of Sativex—a cannabis-derived drug currently used to reduce muscle stiffness and spasms in MS patients—in reducing symptoms of aggression and agitation. The researchers are looking to recruit 60 participants with Alzheimer’s between the ages of 55 and 90 who experience agitation and aggression. If successful, the trial will be followed up with a larger study.
Search Grass for Geezers
Latest Posts
- New Cannabis Statistics: Increased use during COVID; geriatric use increased 75% for insomnia and anxiety; NJ study for employers– Workman’s Comp claims declined 20% with access to medical cannabis
- CBD Oil Can Be Helpful for Stressed Parrots: Feather-plucking, excessive screeching, loss of appetite.
- Who’s Who in Cannabis Research
- COVID-19 Good News and Bad News
- Terpenes as Possible COVID-19 Treatment?
Categories
- Business
- Colorado
- Dede's News
- General Information
- New Products
- New Research
- Newsletter
- Questions
- Reddit Postings
- Reference Sites
- Research
- Addiction
- ALS
- Alzheimer's
- Anxiety
- Apps
- Arthritis
- Asthma
- Autism
- Cancer
- cancer: lung
- CBD Oil
- Charlotte's Web
- Colitis
- Crohns's
- Depression
- Diabetes
- Driving Safety
- End of Life
- Glaucoma
- Glioblastoma Multiforme (GBM)
- Gynecological uses
- Hearing
- Heart Disease
- IBD
- Macular degeneration
- Melanoma
- Memory
- Mesothelioma
- MRSA / Antibiotic resistance
- Multiple Sclerosis (MS)
- Multiple Sclerosis MS
- Neuropathy
- Opioids and Cannabis
- Osteoporosis
- Pain Management
- Parkinson's
- Prostate Cancer
- Psilocybin
- PTSD
- Rick Simpson Oil
- SAD Seasonal Affective Disorder
- Sex
- Sleep
- Sleep Apnea
- Smoking
- Terpenes
- Spirituality
Leave a Reply